ALB and cancer: Low‐serum albumin levels, impaired performance status (ECOG‐PS ≥ 2), cancers with known high mortality rates [50], and advanced stage at diagnosis (Stage III or IV) also maintained a positive association with mortality and cancer progression in all regression models (Table 2).